Zai Lab (ZLAB) Other Non-Current Assets (2016 - 2026)

Zai Lab (ZLAB) posted quarterly Other Non-Current Assets of $3.2 million for Q1 2026, up 25.02% year-on-year from $2.5 million in Q1 2025, and up 3.73% on a QoQ basis from $3.1 million in Q4 2025.

Zai Lab (ZLAB) Other Non-Current Assets (2016 - 2026) Analysis & Trends

Zai Lab (ZLAB) has reported Other Non-Current Assets for 11 consecutive years, with $3.2 million the latest figure, recorded in Q1 2026.

  • Quarterly Other Non-Current Assets rose 25.02% year-over-year to $3.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.2 million (up 25.02% YoY) and the FY2025 annual result came in at $3.1 million, down 47.05% from the prior year.
  • Other Non-Current Assets advanced to $3.2 million in Q1 2026 per ZLAB's latest filing, from $3.1 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for ZLAB reached as high as $5.8 million in Q4 2024 and fell as low as $803000.0 in Q1 2022.
  • A 5-year average of $2.0 million and a median of $1.5 million in 2024 frame the typical range for Other Non-Current Assets.
  • Annual changes were most pronounced in 2024 — Other Non-Current Assets surged 377.09% — and 2025, when it plunged 47.05%.
  • Year by year, Other Non-Current Assets stood at $1.4 million in 2022, then decreased by 13.4% to $1.2 million in 2023, then jumped by 377.09% to $5.8 million in 2024, then tumbled by 47.05% to $3.1 million in 2025, then increased by 3.73% to $3.2 million in 2026.
  • According to Business Quant data, Other Non-Current Assets over the past three periods registered $3.2 million, $3.1 million, and $2.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 1.02 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 104.24 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.26 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 2.13 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 124.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 14.48 Mn
10 Zai Lab 22.02 Bn 22.02 Bn 61.30 Mn 3.17 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.17 Mn
Dec 31, 2025 3.05 Mn
Sep 30, 2025 2.13 Mn
Jun 30, 2025 2.60 Mn
Mar 31, 2025 2.53 Mn
Dec 31, 2024 5.77 Mn
Sep 30, 2024 1.12 Mn
Jun 30, 2024 1.44 Mn
Mar 31, 2024 1.48 Mn
Dec 31, 2023 1.21 Mn
Sep 30, 2023 1.79 Mn
Jun 30, 2023 1.79 Mn
Mar 31, 2023 1.32 Mn
Dec 31, 2022 1.40 Mn
Sep 30, 2022 803,000.00
Jun 30, 2022 803,000.00
Mar 31, 2022 803,000.00
Dec 31, 2021 803,000.00
Sep 30, 2021 743,000.00
Jun 30, 2021 743,000.00